CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
In vitro antibacterial property assessment of silver nanoparticles synthesized by Falcaria vulgaris aqueous extract against MDR bacteria
Authors
A. Barzegari
I. Kohsari
+7 more
M.F. Koudehi
S. Minaeian
S. Mirsadeghi
M. Mohammad-Zadeh
S.M. Pourmortazavi
M. Rezaee
Z. Shariatinia
Publication date
1 January 2019
Publisher
Abstract
Silver nanoparticles (AgNPs) were fabricated in the presence of Falcaria vulgaris aqueous extract as a biosynthesis method without utilizing any surfactant or template. AgNPs were prepared under different synthesis conditions such as silver ion concentration and the amount of plant used for the extraction, reaction duration and temperature for the extraction. The effect of these variables on the size of resulted AgNPs was examined, and operation conditions were optimized statistically with analysis of variance (ANOVA) to describe the role of these variables in tuning the size of AgNPs. The results of ANOVA displayed the optimum conditions for the synthesis procedure that resulted in AgNPs with the average size of 28 ± 8 nm. Furthermore, the growth of AgNPs was monitored by UV-Vis spectroscopy, and they were characterized using TEM, SEM, X-ray diffraction, and FT-IR spectroscopy. Finally, in vitro antibacterial activity of the AgNPs showed the maximum inhibition zone alongside Staphylococcus aureus (ATCC 25923) and lowermost inhibition zone touching E. coli (MDR). The minimum inhibitory concentration (MIC) for the AgNP-Fv was in a range between 0.535 and 0.001 µg/ml. According to the results, the ATCC bacteria were more sensitive to AgNP-Fv compared to multiple-drug resistance bacteria, except for Pseudomonas aeruginosa (MDR). Figure not available: see fulltext.. © 2019, Springer Science+Business Media, LLC, part of Springer Nature
Similar works
Full text
Available Versions
eprints Iran University of Medical Sciences
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:eprints.iums.ac.ir:15454
Last time updated on 01/12/2020